Synopsis
Synopsis
0
USDMF
0
CEP/COS
0
EU WC
0
NDC API
0
VMF
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
1. Alteporina
2. Cefminox Sodium
3. Mt 141
4. Mt-141
5. Tencef
1. 84305-41-9
2. Cefminox [inn]
3. Cefminox Sodium
4. Cmnx
5. Mt-141
6. 75481-73-1
7. Cefminox (inn)
8. Pw08y13465
9. (6r,7s)-7-[[2-[(2s)-2-amino-2-carboxyethyl]sulfanylacetyl]amino]-7-methoxy-3-[(1-methyltetrazol-5-yl)sulfanylmethyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic Acid
10. 5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic Acid, 7-(((((2s)-2-amino-2-carboxyethyl)thio)acetyl)amino)-7-methoxy-3-(((1-methyl-1h-tetrazol-5-yl)thio)methyl)-8-oxo-, (6r,7s)-
11. Cefminoxum
12. Mt 141
13. Cefminoxum [latin]
14. Ccris 5270
15. Ncgc00181749-01
16. Unii-pw08y13465
17. Cefminox [mi]
18. Cefminox [who-dd]
19. Mt-141 Free Acid
20. Schembl49565
21. 5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic Acid, 7-((((2-amino-2-carboxyethyl)thio)acetyl)amino)-7-methoxy-3-(((1-methyl-1h-tetrazol-5-yl)thio)methyl)-8-oxo-, (6r-(6alpha,7alpha,7(s*)))-
22. Chembl1276342
23. Chebi:135817
24. Dtxsid301016174
25. Zinc3938624
26. Akos015895987
27. Db09062
28. D07642
29. 481c731
30. Q5057239
31. (6r,7s)-7-(2-(((s)-2-amino-2-carboxyethyl)thio)acetamido)-7-methoxy-3-(((1-methyl-1h-tetrazol-5-yl)thio)methyl)-8-oxo-5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic Acid
32. (6r,7s)-7-(2-{[(2s)-2-amino-2-carboxyethyl]sulfanyl}acetamido)-7-methoxy-3-{[(1-methyl-1h-tetrazol-5-yl)sulfanyl]methyl}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic Acid
33. (7s)-7-(2-{[(2s)-2-amino-2-carboxyethyl]sulfanyl}acetamido)-7-methoxy-3-{[(1-methyl-1h-tetrazol-5-yl)sulfanyl]methyl}-3,4-didehydrocepham-4-carboxylic Acid
34. 5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic Acid, 7-((((2-amino-2-carboxyethyl)thio)acetyl)amino)-7-methoxy-3-(((1-methyl-1h-tetrazol-5-yl)thio)methyl)-8-oxo-, (6r-(6.alpha.,7.alpha.,7(s*)))-
35. 5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic Acid, 7-((2-(((2s)-2-amino-2-carboxyethyl)thio)acetyl)amino)-7-methoxy-3-(((1-methyl-1h-tetrazol-5-yl)thio)methyl)-8-oxo-, (6r,7s)-
Molecular Weight | 519.6 g/mol |
---|---|
Molecular Formula | C16H21N7O7S3 |
XLogP3 | -4 |
Hydrogen Bond Donor Count | 4 |
Hydrogen Bond Acceptor Count | 14 |
Rotatable Bond Count | 11 |
Exact Mass | 519.06645956 g/mol |
Monoisotopic Mass | 519.06645956 g/mol |
Topological Polar Surface Area | 279 Ų |
Heavy Atom Count | 33 |
Formal Charge | 0 |
Complexity | 862 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 3 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 1 |
Anti-Bacterial Agents
Substances that inhibit the growth or reproduction of BACTERIA. (See all compounds classified as Anti-Bacterial Agents.)
J - Antiinfectives for systemic use
J01 - Antibacterials for systemic use
J01D - Other beta-lactam antibacterials
J01DC - Second-generation cephalosporins
J01DC12 - Cefminox
Market Place
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
81
PharmaCompass offers a list of Cefminox Sodium API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Cefminox Sodium manufacturer or Cefminox Sodium supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Cefminox Sodium manufacturer or Cefminox Sodium supplier.
PharmaCompass also assists you with knowing the Cefminox Sodium API Price utilized in the formulation of products. Cefminox Sodium API Price is not always fixed or binding as the Cefminox Sodium Price is obtained through a variety of data sources. The Cefminox Sodium Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A CMNX manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of CMNX, including repackagers and relabelers. The FDA regulates CMNX manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. CMNX API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of CMNX manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A CMNX supplier is an individual or a company that provides CMNX active pharmaceutical ingredient (API) or CMNX finished formulations upon request. The CMNX suppliers may include CMNX API manufacturers, exporters, distributors and traders.
click here to find a list of CMNX suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.
The CMNX Drug Master File in Japan (CMNX JDMF) empowers CMNX API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).
PMDA reviews the CMNX JDMF during the approval evaluation for pharmaceutical products. At the time of CMNX JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.
click here to find a list of CMNX suppliers with JDMF on PharmaCompass.
In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a CMNX Drug Master File in Korea (CMNX KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of CMNX. The MFDS reviews the CMNX KDMF as part of the drug registration process and uses the information provided in the CMNX KDMF to evaluate the safety and efficacy of the drug.
After submitting a CMNX KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their CMNX API can apply through the Korea Drug Master File (KDMF).
click here to find a list of CMNX suppliers with KDMF on PharmaCompass.
CMNX Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of CMNX GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right CMNX GMP manufacturer or CMNX GMP API supplier for your needs.
A CMNX CoA (Certificate of Analysis) is a formal document that attests to CMNX's compliance with CMNX specifications and serves as a tool for batch-level quality control.
CMNX CoA mostly includes findings from lab analyses of a specific batch. For each CMNX CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
CMNX may be tested according to a variety of international standards, such as European Pharmacopoeia (CMNX EP), CMNX JP (Japanese Pharmacopeia) and the US Pharmacopoeia (CMNX USP).